Literature DB >> 23893775

Parahemophilia: new insights into factor v deficiency.

Nabil Thalji1, Rodney M Camire.   

Abstract

Blood coagulation factor V (FV) plays a pivotal role in blood coagulation. It is found in both plasma and in platelets and has a profound impact on thrombin generation. Deficiency of this clotting factor due to inherited or acquired conditions results in a broad spectrum of bleeding symptoms. Surprisingly however, some patients with undetectable levels of FV experience relatively mild bleeding. The aim of this review is to highlight this rare coagulation factor disorder and touch upon its clinical manifestations, diagnosis, and treatment. Furthermore, recent advances that shed new light on the importance of platelet FV and other modifiers which influence bleeding tendencies in severe FV deficiency will be discussed. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23893775     DOI: 10.1055/s-0033-1349224

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  8 in total

1.  Platelets contain tissue factor pathway inhibitor-2 derived from megakaryocytes and inhibits fibrinolysis.

Authors:  Kanagasabai Vadivel; Sathya-Moorthy Ponnuraj; Yogesh Kumar; Anne K Zaiss; Matthew W Bunce; Rodney M Camire; Ling Wu; Denis Evseenko; Harvey R Herschman; Madhu S Bajaj; S Paul Bajaj
Journal:  J Biol Chem       Date:  2014-09-28       Impact factor: 5.157

2.  Analysis of factor V in zebrafish demonstrates minimal levels needed for early hemostasis.

Authors:  Angela C Weyand; Steve J Grzegorski; Megan S Rost; Kari I Lavik; Allison C Ferguson; Marzia Menegatti; Catherine E Richter; Rosanna Asselta; Stefano Duga; Flora Peyvandi; Jordan A Shavit
Journal:  Blood Adv       Date:  2019-06-11

Review 3.  Treatment of rare factor deficiencies in 2016.

Authors:  Flora Peyvandi; Marzia Menegatti
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

4.  Development and Characterization of a Factor V-Deficient CRISPR Cell Model for the Correction of Mutations.

Authors:  Luis Javier Serrano; Mariano Garcia-Arranz; Juan A De Pablo-Moreno; José Carlos Segovia; Rocío Olivera-Salazar; Damián Garcia-Olmo; Antonio Liras
Journal:  Int J Mol Sci       Date:  2022-05-22       Impact factor: 6.208

5.  Phenotype Report on Patients with Congenital Factor V Deficiency in Southern Iran: Recent Ten Years' Experience.

Authors:  Mohammad Mostafa Safarpour; Sezaneh Haghpanah; Aidin Meshksar; Mehran Karimi
Journal:  Turk J Haematol       Date:  2017-03-08       Impact factor: 1.831

6.  Clinical Phenotype and Genetic Analysis of Twins With Congenital Coagulation Factor V Deficiency.

Authors:  Yanhui Wei; Yuzhuo He; Xuejun Guo
Journal:  J Pediatr Hematol Oncol       Date:  2022-03-01       Impact factor: 1.170

7.  Genetic Confirmation of Congenital Factor V Deficiency in Korean Patients.

Authors:  Chang-Hun Park; Kiyoung Yoo; Ki-O Lee; Sun-Hee Kim; Ki-Woong Sung; Hee-Jin Kim
Journal:  Ann Lab Med       Date:  2016-03       Impact factor: 3.464

8.  [Factor V congenital deficiency: about a case].

Authors:  Saloua Boujrad; Brahim El Hasbaoui; Hanae Echahdi; Mohamed Malih; Aomar Agadr
Journal:  Pan Afr Med J       Date:  2017-07-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.